Rahika 150mg Tablet
By Rahika
Rx
12 Tablet in a Strip

Composition
Capmatinib(150mg)

Manufacturer - Novartis India Ltd
Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India

Expires on or after
July, 2025

liver
When taking Rahika 150mg Tablet, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when using Rahika 150mg Tablet. It is advised to consult your doctor for guidance on the appropriate dosage in such cases.

kidney
Rahika 150mg Tablet can be safely used by patients with kidney disease. No change in dosage is needed for Rahika 150mg Tablet.

alcohol
Consult your doctor when consuming alcohol with Rahika 150mg Tablet.

driving
It is advisable not to drive if you encounter any symptoms that hinder your focus and reaction while using Rahika 150mg Tablet. It is uncertain if this medication affects driving ability.

pregnancy
Rahika 150mg Tablet may not be safe to use during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will assess the risks versus benefits before prescribing this medication. Please consult your doctor.

breastfeeding
Rahika 150mg Tablet is not recommended during breastfeeding, as it may potentially pass into the breastmilk and pose a risk to the baby.
Habit Forming | No |
Chemical Class | Quinazoline Derivative |
Therapeutic Class | - |
Action Class | Protein synthesis inhibitors |
₹14500
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025